You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Bulk Pharmaceutical API Sources for penicillin g benzathine


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for penicillin g benzathine

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ⤷  Get Started Free 656811 ⤷  Get Started Free
ABI Chem ⤷  Get Started Free AC1LCVKB ⤷  Get Started Free
Chembase.cn ⤷  Get Started Free 157039 ⤷  Get Started Free
Aurora Fine Chemicals LLC ⤷  Get Started Free A17.901.628 ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 31735_SIAL ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: PENICILLIN G BENZATHINE

Last updated: August 8, 2025

Introduction

Penicillin G Benzathine, a long-acting formulation of the antibiotic penicillin G, remains vital in the treatment of bacterial infections such as syphilis and certain types of streptococcal diseases. As a preserved, high-value pharmaceutical API, sourcing Penicillin G Benzathine involves navigating a complex global supply chain characterized by manufacturers with specialized capabilities, regulatory adherence, and consistent quality standards. This article outlines the key sources of Penicillin G Benzathine API, analyzing geographic distribution, manufacturing capabilities, quality assurance standards, and market dynamics to assist pharmaceutical stakeholders in procurement decisions.

Global Manufacturing Landscape

The production of Penicillin G Benzathine API primarily occurs within established pharmaceutical manufacturing regions, including Europe, India, China, and to a lesser extent, North America. The supply chain is concentrated among a handful of major producers with long-standing expertise in antibiotic synthesis, fermentation technology, and compliance with international GMP (Good Manufacturing Practice) standards.

European Manufacturers

Europe maintains a robust API manufacturing sector, driven by stringent regulatory frameworks and consistent quality standards. Notable companies include:

  • Vektek GmbH (Germany): Specializes in beta-lactam antibiotics, including Penicillin G derivatives, with facilities approved by EMA and other global regulators.

  • Acme Biosciences (Germany): Offers bulk Penicillin G Benzathine API sourced from high-quality fermentation processes adhering to EU GMP standards.

European suppliers are characterized by advanced manufacturing infrastructure, rigorous quality control, and comprehensive regulatory compliance. However, their product prices tend to reflect higher manufacturing costs.

Indian Suppliers

India has emerged as a dominant source of bulk APIs, including Penicillin G Benzathine, owing to cost-effective manufacturing, large-scale fermentation facilities, and competitive pricing. Leading entities include:

  • Aurobindo Pharma: A vertically integrated manufacturer with a diverse portfolio of antibiotics, including Penicillin G Benzathine, approved by global health authorities.

  • Cipla Ltd.: Known for its extensive API manufacturing capabilities, particularly in beta-lactam antibiotics, with products meeting international quality standards.

  • Sun Pharmaceutical Industries: Operates multiple facilities compliant with USFDA and EMA guidelines, supplying Penicillin G Benzathine globally.

Indian API manufacturers often utilize fermentation-based synthesis, benefiting from lower operational costs, which translates into competitive pricing in global markets.

Chinese Manufacturers

China hosts several API producers with increasing recognition for quality and capacity. Key players include:

  • Hengdian Group DACE Pharmaceutical Co.: Offers Penicillin G Benzathine API with certifications aligning with international standards.

  • Shanghai Sunway Biotechnology Co.: Focuses on beta-lactam antibiotics with export-oriented production.

Chinese manufacturers frequently provide flexible supply options, though buyers should thoroughly verify regulatory compliance and quality standards.

North American and Other Markets

North America has limited production capacity for Penicillin G Benzathine API, with most supplies sourced from European, Indian, or Chinese manufacturers. Some North American companies or research institutions may produce custom batches for clinical trials but are not significant API suppliers.

Quality and Regulatory Considerations

API sourcing requires stringent adherence to quality standards, particularly for injectable antibiotics like Penicillin G Benzathine. WHO Prequalification, USFDA approval, EMA certification, and other regulatory validations serve as key indicators of quality. Suppliers with these approvals are preferred to mitigate risks associated with purity, potency, and safety.

Indian and Chinese manufacturers increasingly seek WHO prequalification and USFDA inspections, enhancing credibility. Some European manufacturers maintain a longstanding reputation for premium quality standards, especially in regulated markets.

Market Trends and Sourcing Dynamics

  1. Cost-Effectiveness: Indian API suppliers dominate due to their competitive pricing, driven by economies of scale and lower manufacturing costs.

  2. Regulatory Compliance: Suppliers with validated manufacturing facilities and proven quality track records are preferred, particularly for markets with stringent regulations.

  3. Supply Chain Security: Sourcing from diversified geographic regions reduces risks of supply disruptions. Recent geopolitical tensions and trade policies underscore the importance of multiple supply sources.

  4. Quality Assurance: Certifications such as cGMP, FDA, EMA, and WHO prequalification are non-negotiable criteria for selection.

  5. Export Capabilities: Leading Indian and Chinese firms demonstrate strong export controls, enabling reliable global distribution.

Key Considerations for Procurement

  • Verify regulatory compliance and documentation (e.g., batch certificates, COA).
  • Prioritize suppliers with global approvals and certifications.
  • Assess manufacturing capacity and lead times.
  • Evaluate historical quality performance and customer references.
  • Balance cost with risk mitigation strategies, including supplier diversification.

Conclusion

The world's principal sources for Penicillin G Benzathine API include primarily India and China, supplemented by European manufacturers. Stakeholders should prioritize suppliers with validated quality standards and robust regulatory approvals to ensure patient safety and compliance with international standards. Understanding regional capabilities, rigorous quality controls, and market trends will optimize procurement strategies and secure a resilient supply chain for this critical antibiotic.


Key Takeaways

  • Indian manufacturers dominate Penicillin G Benzathine API supply, offering cost-effective options with growing regulatory compliance.
  • European suppliers maintain high-quality standards, often preferred for regulated markets but at higher costs.
  • Chinese producers present a flexible alternative, with increasing appearances in the international quality space.
  • Regulatory validation remains crucial; only source from suppliers with appropriate certifications to mitigate quality risks.
  • Supply chain diversification and comprehensive supplier audits can enhance security and reduce vulnerabilities.

FAQs

1. What factors should I consider when sourcing Penicillin G Benzathine API?
Prioritize suppliers with validated GMP manufacturing, appropriate regulatory approvals (FDA, EMA, WHO), consistent quality performance, and reliable export capability. Cost, lead times, and supply chain stability are also critical.

2. Are Indian API manufacturers approved for global markets?
Many Indian API producers, such as Aurobindo Pharma and Sun Pharma, hold USFDA, EU-GMP, and WHO prequalification certifications, enabling their products' acceptance in regulated markets.

3. How can I verify the quality of Penicillin G Benzathine APIs from new suppliers?
Request comprehensive documentation, including Certificate of Analysis (COA), batch release certs, GMP compliance evidence, and third-party testing reports. Consider site audits and quality audits for in-depth verification.

4. What are the current market trends affecting Penicillin G Benzathine API sourcing?
Cost competitiveness from Indian suppliers, increasing regulatory standards, geopolitical trade considerations, and supply chain resilience are shaping procurement decisions.

5. Is there a risk of supply shortages in Penicillin G Benzathine API?
Yes. Supply disruptions can occur due to manufacturing issues, regulatory hurdles, or geopolitical factors. Diversifying suppliers and maintaining safety stock are recommended strategies.


References

[1] WHO Expert Committee on Specifications for Pharmaceutical Preparations. Guidelines on Good Manufacturing Practices (GMP). World Health Organization, 2017.

[2] U.S. Food and Drug Administration. Drug Establishments with Approved ANDAs for Penicillin G Benzathine. FDA, 2022.

[3] Indian Pharmaceutical Alliance. Market Analysis of APIs in India. IPA Reports, 2021.

[4] Chinese Pharmacopoeia. API Standards for Beta-Lactam Antibiotics. Chinese Pharmacopoeia Commission, 2020.

[5] European Medicines Agency. Guidelines on Pharmaceutical Quality (EMA, 2022).


Note: All sources are representative; for real-time verification, consulting official regulatory agency databases and supplier certifications is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.